Skip to main content
Physiological Reports logoLink to Physiological Reports
. 2021 Sep 23;9(18):e15054. doi: 10.14814/phy2.15054

Ozone‐induced changes in the murine lung extracellular vesicle small RNA landscape

Gregory J Smith 1,, Adelaide Tovar 1, Matt Kanke 2, Yong Wang 3, Jessy S Deshane 3, Praveen Sethupathy 2, Samir N P Kelada 2
PMCID: PMC8461034  PMID: 34558223

Abstract

Inhalation exposure to ozone (O3) causes adverse respiratory health effects that result from airway inflammation, a complex response mediated in part by changes to airway cellular transcriptional programs. These programs may be regulated by microRNAs transferred between cells (e.g., epithelial cells and macrophages) via extracellular vesicles (EV miRNA). To explore this, we exposed female C57BL/6J mice to filtered air (FA), 1, or 2 ppm O3 by inhalation and collected bronchoalveolar lavage fluid (BALF) 21 h later for markers of airway inflammation, EVs, and EV miRNA. Both concentrations of O3 significantly increased markers of inflammation (neutrophils), injury (total protein), and the number of EV‐sized particles in the BALF. Imagestream analysis indicated a substantial portion of particles was positive for canonical EV markers (CD81, CD51), and Siglec‐F, a marker of alveolar macrophages. Using high‐throughput small RNA sequencing, we identified several differentially expressed (DE) BALF EV miRNAs after 1 ppm (16 DE miRNAs) and 2 ppm (99 DE miRNAs) O3 versus FA exposure. O3 concentration‐response patterns in EV miRNA expression were apparent, particularly for miR‐2137, miR‐126‐3p, and miR‐351‐5p. Integrative analysis of EV miRNA expression and airway cellular mRNA expression identified EV miR‐22‐3p as a candidate regulator of transcriptomic responses to O3 in airway macrophages. In contrast, we did not identify candidate miRNA regulators of mRNA expression data from conducting airways (predominantly composed of epithelial cells). In summary, our data show that O3 exposure alters EV release and EV miRNA expression, suggesting that further investigation of EVs may provide insight into their effects on airway macrophage function and other mechanisms of O3‐induced respiratory inflammation.

Keywords: air pollution, exosomes, extracellular vesicles, inflammation, lung, microRNA, mouse, ozone


Respiratory exposure to the common ambient air pollutant, ozone, causes airway inflammation and injury. Using high‐throughput RNA sequencing, we investigated whether ozone‐induced inflammation was associated with altered lung extracellular vesicle small RNA expression. We found that specific extracellular vesicle miRNAs, including miR‐22‐3p, were altered by ozone exposure that may affect the function of airway cells.

graphic file with name PHY2-9-e15054-g003.jpg

1. INTRODUCTION

Ozone (O3) is a highly reactive, oxidant air pollutant associated with significant adverse respiratory health effects including airway inflammation and exacerbation of respiratory diseases such as asthma (Al‐Hegelan et al., 2011). Observations of the health effects of O3 date to the mid‐19th century (Schönbein,), and yet, knowledge of the underlying mechanisms is still incomplete. Ground level O3 concentrations in many regions regularly exceed the current US national standard (0.07 ppm) (U.S. Environmental Protection Agency, 2020) and O3‐induced airway inflammation can occur at even lower concentrations (Kim et al., 2011). Given that ambient O3 concentrations are expected to rise in the coming decades due to climate change (Pfister et al., 2014), research to identify the mechanisms by which O3 causes respiratory health effects is still an imperative.

Inhaled O3 reacts rapidly with the airway surface lining liquid to generate reactive oxygen species, lipid peroxides, and other products that induce a complex and dynamic respiratory tract response (Mudway & Kelly, 2000; Pryor et al., 1995). Inflammation occurs up to 48 h following a single exposure, initiated in part, by the release of cytokines and marked by edema and the influx of neutrophils to the lung (Mudway & Kelly, 2000). Following the cessation of exposure, the anti‐inflammatory and pro‐resolving activities of the respiratory tract and innate immune cells restore homeostasis by about 72 h (Kilburg‐Basnyat et al.,).

Alveolar macrophages and epithelial cells are two airway cell types with readily apparent functional responses to O3 (Al‐Hegelan et al., 2011). Alveolar macrophages show reduced phagocytosis (Gilmour et al., 1991) and enhanced antigen presentation activity (Lay et al.,). Epithelial cell barrier dysfunction and damage are evidenced by the presence of an intra‐alveolar, albumin‐rich exudate following O3 exposure (Hollingsworth et al., 2007). Shared functional responses, albeit differing with respect to timing and precise mediators, include the release of pro‐inflammatory cytokines (e.g., IL‐6 (Devlin et al., 1991), IL‐1 family (Michaudel et al., 2016), TNFα (Fakhrzadeh et al., 2008)) and altered production/activity of other proteins (e.g., surfactant (Haque et al., 2007), metallothionein (Inoue et al., 2008), matrix metalloproteinases (Yoon et al., 2007)), and small molecules (e.g., antioxidants (Behndig et al., 2009), eicosanoids (Devlin et al., 1991), specialized pro‐resolving lipid mediators (Kilburg‐Basnyat et al.,)).

Underlying the functional cellular responses of airway macrophage and epithelial cells to O3 are alterations in inflammatory, immune, and oxidative stress response gene expression programs. Transcriptomic and proteomic studies have better illuminated the landscape of gene expression responses to O3, revealing the involvement of the protease/anti‐protease system (Kesic et al., 2012), heat shock proteins (Nadadur et al., 2005), NRF2 (Cho et al., 2013, 2013), and NF‐kB family transcription factors (Jaspers et al., 1997). Although the gene expression landscape of the airway response to O3 is becoming clearer, the precise mechanisms regulating gene expression responses to O3 are unknown.

Extracellular vesicles (EVs) have emerged as an important means of airway intercellular communication and may directly influence gene expression responses of the respiratory tract (Guiot et al., 2019; McVey et al., 2019; Raposo & Stoorvogel, 2013). EVs are a heterogeneous population of nanometer scale, lipid membrane‐bound particles, which includes exosomes and microvesicles (Raposo & Stoorvogel, 2013). EVs carry several classes of cargo including small RNAs such as microRNAs (miRNA) (Crescitelli et al., 2013). miRNAs regulate gene expression post‐transcriptionally by destabilizing or inhibiting the translation of target mRNAs, and a single miRNA can regulate hundreds of different mRNAs (Bartel, 2018). EV‐derived miRNAs (EV miRNAs) are readily detectable in the airway lumen and are taken up by respiratory tract cells including airway macrophages and epithelial cells (Guiot et al., 2019). As such, EVs represent a unique mechanism for the transfer of miRNA and intercellular miRNA‐mediated regulation of airway gene expression.

Inflammatory lung diseases including asthma (Levänen et al., 2013), idiopathic pulmonary fibrosis (Njock et al., 2018), and chronic obstructive pulmonary disease (COPD) (Fujita et al., 2015) as well as oxidant‐ or allergen‐induced lung inflammation (Lee et al., 2019; Pua et al., 2019) are associated with altered airway EV miRNA profiles. In addition, there is growing evidence that EV miRNAs directly alter airway cellular gene expression to change cellular phenotype. For example, studies have demonstrated their direct effects on myofibroblast and macrophage differentiation (Ismail et al., 2013; Saha et al., 2016) and protein secretion by epithelial cells (Gupta et al., 2019). Thus, it is likely that EV miRNA play functional roles in O3‐induced inflammation (Andres et al., 2020); however, the extent to which O3 exposure affects EV miRNA expression is unknown. We hypothesized that O3 exposure dysregulates airway EV miRNAs, thereby affecting target mRNA expression in cells of the airway including epithelial cells and macrophages. To investigate this, we conducted high‐throughput small RNA sequencing of miRNA isolated from murine airway EVs following filtered air (FA), 1. and 2 ppm O3 exposure and used an integrative bioinformatics approach to identify putative EV miRNA regulators of gene expression in airway macrophages and conducting airways. Our results provide a characterization of the murine airway EV miRNA landscape after ozone exposure, including specific EV miRNAs that may act as regulators of O3‐induced gene expression changes in the airway.

2. MATERIALS AND METHODS

2.1. Animals

Adult (Cho et al., 2013; Cobos Jiménez et al., 2014; Crescitelli et al., 2013) female C57BL/6J mice were purchased from the Jackson Laboratory and used for all experiments. We used female mice because prior data have shown greater inflammatory responses to O3 in this sex. Specifically, female mice display increased pro‐inflammatory gene expression profiles, secretion of cytokines and chemokines, and neutrophil influx in response to acute O3 exposure (Cabello et al., 2015; Mishra et al., 2016), thus focusing on this sex could provide an opportunity to detect a more dynamic transcriptional response. Mice were housed in cages at a maximum density of five per cage on ALPHA‐Dri bedding (Shepard) under standard 12 h lighting conditions, with ad libitum access to food (Envigo 2929) and water. After a 1‐week acclimation period, mice were randomly assigned to different exposure groups. The sample size for each group is indicated in the figure legends. All experiments were conducted within an AAALAC approved facility and were approved by the Institutional Animal Care and Use Committee (IACUC) at the University of North Carolina at Chapel Hill.

2.2. Ozone exposures

Whole body inhalation exposures to filtered air (FA), 1, or 2 ppm O3 for 3 h were conducted as previously described (Smith et al., 2019; Tovar et al., 2020). Environmental conditions for each experiment, including mean O3 concentration (Supplemental Figure S1), temperature, and relative humidity were recorded (Supplemental Table S1).

2.3. Bronchoalveolar lavage

Mice were euthanized 21 h following cessation of exposure with a lethal dose of urethane (2 g/kg, i.p.) followed by exsanguination. We chose a 21‐h time point based on our previous work (Tovar et al., 2020) which showed abundant transcriptional responses to ozone at this time point.

Bronchoalveolar lavage was conducted with a 21‐gauge catheter inserted in the trachea. The lung was then gently lavaged twice (1 × 0.5 ml, 1 × 1 ml) with ice‐cold PBS containing complete protease inhibitor cocktail (Roche) using a 1‐ml syringe. Collected bronchoalveolar lavage fluid (BALF) was centrifuged (400 x g, 10 mins, 4ºC) to pellet cells. Red blood cells were lysed with hypertonic saline and the remaining white blood cells were resuspended in Hank's Balanced Salt Solution and counted by hemocytometer and mounted on slides via cytospin. Cytospin slides were stained with Kwik‐Diff (Shandon). Two investigators, blinded to the exposure group, performed differential cell counts (minimum 300 cells per slide).

2.4. EV isolation and characterization

After the removal of cells from BALF, a second centrifugation was performed (16,000 x g, 10 mins, 4ºC) to pellet cellular debris and larger vesicles (e.g., apoptotic bodies). The concentration and size distribution of particles within the BALF supernatants were measured using the Nanosight NS500 Nanoparticle Tracking Analysis system (Malvern Panalytical) at the UNC Nanomedicines Characterization Core Facility. BALF supernatant samples were diluted 1:100 in 0.02‐μM filtered PBS prior to loading on the NTA instrument. This level of dilution provided visualization of between 10 and 50 particles/frame. Five individual, 40‐s long, motion captures of the suspended particles were analyzed using Nanosight software v3.2 (Malvern Panalytical). Specific camera settings included camera levels of 14–16 and detection thresholds of 4–5. Nanoparticle Tracking Analysis instrument calibration was performed using 100 nm polystyrene beads (Malvern Panalytical).

2.5. ImageStream analysis of EVs

Intact EVs were isolated from BALF using an ExoRNeasy column purification and eluted in 400 µl of buffer XE (Qiagen). ImageStream analysis was performed on eluted EVs (Hough et al., 2018). EVs were stained with the following antibodies: FITC‐conjugated anti‐mouse CD326 (EpCAM, clone G8.8, Life Technologies). PE‐conjugated anti‐mouse CD81 (clone Eat‐2), PE‐Cy7‐conjugated anti‐mouse CD9 (clone MZ3), PE‐Cy7‐conjugated anti‐mouse CD31 (clone 390), Alexa 594‐conjugated anti‐mouse CD11b (clone M1/70), BV421‐conjugated anti‐mouse CD170 (Siglec‐F, clone S17007L), APC‐conjugated anti‐mouse CD63 (clone NVG‐2) and APC‐conjugated anti‐mouse CD170 (Siglec‐F, clone S17007L) purchased from BioLegend. FITC‐conjugated anti‐mouse Ly6G (clone 1A8) and BV421‐conjugated anti‐mouse CD51 (clone RMV‐7) purchased from BD Biosciences. Unstained control, single color staining, and calibration beads were used to calibrate the machine and adjust compensation. The stained samples were imaged at 60X magnification without extended depth of field. The data were acquired on channels Ch01, Ch02, Ch03, Ch04, Ch06, Ch07, Ch09, Ch11, and Ch12. Ch01 and Ch09 were used as bright field channels, whereas Ch12 was used for side‐scatter. A total of 5,000 events were acquired, gating on forward‐ and side‐scatters, as well as aspect ratio and area. The acquired data were analyzed using IDEAS software version 6.2 (EMD Millipore).

2.6. EV small RNA isolation and sequencing

BALF samples were pooled into groups of three to four and total RNA was isolated from pooled samples using an ExoRNeasy Serum/Plasma Midi kit (Qiagen). Column‐bound EVs were lysed with Qiazol and total EV RNA was isolated using a Qiagen RNeasy MinElute spin column (Qiagen). Prior to sequencing, the yield and integrity of small RNA from isolated and lysed EVs were measured using an Agilent 2100 Bioanalyzer with small RNA chip, and an example result is shown in Supplementary Figure S4B. Small RNA sequencing libraries were prepared using a BioO Scientific NEXT Flex‐v3 kit. Single end sequencing was performed on the Illumina HiSeq 4000 platform at the UNC High‐Throughput Sequencing Facility (University of North Carolina, Chapel Hill, NC, USA).

2.7. EV small RNA expression analysis

Using miRquant 2.0 (Kanke et al., 2016), small RNA reads were trimmed of adapters, aligned to the Mus musculus domesticus reference genome (assembly NCBI37/mm9), and miRNAs and isomiRs (miRNA sequence variants) were quantified. Small RNA Bioanalyzer results, read length and mapping statistics are presented in the results section and Supplemental Figures S4 and S5.

In follow‐up analyses, we performed qRT‐PCR to quantify miR‐22 levels. cDNA synthesis was performed on 10 ng of EV‐derived RNA using a TaqMan advanced miRNA cDNA Synthesis kit (ThermoFisher Scientific). miRNA qPCR reactions were performed in triplicate on a BioRad CFX 384 Touch Real‐Time PCR detection system using TaqMan Fast Advanced qPCR Master Mix (ThermoFisher Scientific) according to the manufacturer's instructions. TaqMan Advanced miRNA assays for miR‐22‐3p (mmu481004_mir) and miR‐23a‐3p (mmu478532_mir) were used for RT‐qPCR expression analysis. miR‐23a‐3p was used for normalization based on its low coefficient of variation in expression across samples measured by small RNA sequencing. miRNA levels are expressed as relative quantitative values (RQVs) and statistical analyses were conducted using dCq values.

2.8. EV miRNA target mRNA prediction

miRNA target site enrichment analysis was performed on lists of O3‐responsive genes from our previously published (Tovar et al., 2020) RNA sequencing analysis of airway macrophages (isolated from BALF) and conducting airway tissues (microdissected from lungs preserved in RNAlater (ThermoFisher Scientific) using the bioinformatics algorithm mirRhub (Baran‐Gale et al., 2013). Using a list of up‐ or downregulated genes as an input, miRhub was used to determine if any miRNA target sites were significantly over represented in these lists of previously identified O3‐responsive genes (Tovar et al., 2020) compared to randomly generated gene lists. Only miRNAs that were conserved in two other species and whose expression was directionally opposed to the tissue mRNA patterns across the exposure groups were considered. For a designated contrast, both the miRNA and mRNA were required to be significantly differentially expressed (fold change of ±2, p‐adjusted <0.05).

2.9. Statistical analysis

Statistical analyses were conducted using R (version 3.6.1). For analysis presented in Figure 1b, and Supplemental Figure S2 a Box‐Cox procedure was used to determine an appropriate transformation of the data to reduce heteroscedasticity and conform to a normal distribution prior to ANOVA and Tukey's HSD post hoc tests for group comparisons. In Figure 1c, d, linear regression models were used to determine whether any statistically significant concentration–response trends were present. T‐tests were used for Figure 2 to compare 2 ppm O3 to the FA group.

FIGURE 1.

FIGURE 1

O3 exposure causes increases in EV‐sized particles in the lung. Female C57BL/6J mice were exposed to filtered air (FA; n = 12), 1 (n = 9), or 2 (n = 9) ppm O3 for 3 hours and bronchoalveolar lavage fluid was collected 21 hours later for isolation and analysis of extracellular vesicles. (A) Size distribution, (B) total concentration, (C) size mean, and (D) size mode of particles in BALF samples were measured by nanoparticle tracking analysis. Results are depicted in (A) as the mean particle‐size distribution. In (B‐D) Box‐and‐Whisker plots depict the minimum, first quartile, median, third quartile, and maximum of the data with all points overlaid. a: p < 0.05 compared to the FA group, b: p < 0.05 compared to the 1 ppm group. In (C) and (D), linear regression models demonstrated significant relationship between O3 concentration and size, mean and mode, p‐value =0.016 and 0.049, respectively

FIGURE 2.

FIGURE 2

Imaging flow cytometry analysis of BALF EVs. Percentage of EVs positive for (A) CD81, (B) CD51, (C) Siglec‐F, (D) EpCAM, (E) Ly6G, (F) CD81 and Siglec‐F, (G) CD81 and Ly6G, (H) CD51 and Siglec‐F, and (I) CD51 and Ly6G. EVs were isolated for ImageStream analysis from mice 21 hours following a 3‐hour exposure to FA or 2 ppm O3. n = 6 per group. Need to add some indication of stat test results here

3. RESULTS

3.1. Ozone (O3) inhalation causes inflammation and increased extracellular vesicle (EV)‐sized particles in the lung

We exposed female C57BL6/J mice to filtered air (FA), 1, or 2 ppm O3 for 3 h and collected bronchoalveolar lavage fluid (BALF) 21 h later for isolation of EVs and measurement of lung inflammation and injury. As previously reported (Tovar et al., 2020), BALF samples from both 1‐ and 2‐ppm O3‐exposed mice exhibited characteristic pulmonary inflammatory phenotypes including significant increases in cellularity, driven primarily by neutrophils, and injury as measured by increased total protein compared to FA (control) mice (Supplemental Figure S2). Both tissue injury and inflammation were most severe in the 2‐ppm O3‐exposed group compared to the 1‐ppm O3 group.

We measured the number of particles in BALF supernatants across a size range of ~50–1000 nm by nanoparticle tracking analysis. We observed a concentration‐dependent increase in the total number of particles in the size range of EVs, roughly 50–400 nm (Figure 1a). The increase in BALF particle concentration was statistically significant at 2 ppm O3 compared to the 1‐ppm O3 and FA groups (Figure 1b). Additionally, we observed modest shifts in the particle size distributions across treatment groups, with both the means and modes of particle size indicating a statistically significant decreasing trend from FA to 2 ppm O3 (Figure 1c, d). In an independent experiment, we compared the particle distributions in BALF supernatants (as in Figure 1a, b) with the distribution of BALF EVs isolated by membrane affinity column separation from aliquots of the same BAL supernatant samples (Supplemental Figure S3). Although column purification reduced the overall particle number, an increase in particle number remained evident in post‐column EVs from mice exposed to 2 ppm O3 compared to FA.

3.2. EV characterization by imaging flow cytometry

To assess the relative proportions of exosomes and microvesicles in BALF EV samples and provide estimates of their cellular source(s), we isolated and eluted intact BALF EVs for imaging flow cytometry. We observed a high proportion of BALF EVs expressing typical markers of exosomes (~25–40%, CD81) and microvesicles (~20%, CD51), respectively (Figure 2). Expression of other markers indicative of cell‐type origin, such as Siglec‐F (alveolar macrophages), EpCAM (epithelial cells), CD11b (non‐resident monocytes/macrophages), and Ly6G (neutrophils), each comprised a small proportion of the total EV particles (Figure 2 and Supplemental Table S2). There were more Ly6G‐positive EVs and exosomes (CD81+, Ly6G+) in 2‐ppm O3‐exposed mice (Figure 2 and Supplemental Table S2). We did not detect statistically significant effects of O3 exposure on the expression of the other EV or cell‐type markers, although an increase in exosomes (EVs expressing CD81) was noted (Figure 2a).

3.3. Ozone (O3) induces miRNA expression changes in lung EVs

To obtain sufficient quantities of small RNA for downstream sequencing, we pooled BALF from three to four mice per treatment group, isolated EV‐total RNA from each of the pools, and characterized RNA abundance and size distributions. RNA abundance did not differ between groups (Supplemental Figure S4a), and RNA contents from each pool were predominantly in the size range of 20–40 nucleotides (Supplemental Figure S4b). To identify O3‐responsive EV miRNAs, we performed high‐throughput small RNA sequencing (small RNA‐seq) on each of the pooled EV RNA samples (n = 3 pools/exposure group). We obtained 44 million reads per sample on average, 78% of which were unambiguously mapped to the reference mouse genome (Supplemental Figure S5a). The bulk of mapped reads (~70–90%) were in the range of 30–35 nucleotides and mapped to tRNA, suggestive of tRNA‐derived RNA fragments (tDRs) (Supplemental Figure S5b and c). miRNAs constituted 1–2% of mapped reads, and the balance consisted of other small, unannotated RNAs (e.g., yRNAs, partially degraded longer RNAs.). Across exposure groups, we observed an increase in the percentage of reads mapped to these other small RNAs and a decrease in reads mapped to tRNAs, while the percentage of miRNA was reduced by half in the 2‐ppm O3 exposure group from ~2 to ~1%. Despite their relatively low abundance, we focused on EV miRNAs because of their known roles in modifying gene expression in target cells (Bartel, 2018; Raposo & Stoorvogel, 2013; Zhang et al., 2019).

We performed principal component analysis (PCA) on the 50 most variably expressed EV miRNAs, which revealed distinct EV miRNA expression patterns by exposure (Figure 3a). Using a threshold of fold change of ±2, p‐adjusted <0.05, and expression level of >50 reads per million miRNAs mapped (RPMMM), we identified 16 significantly differentially expressed EV miRNAs after 1 ppm O3 exposure and 99 significantly differentially expressed EV miRNAs after 2 ppm O3 exposure (Figure 3b, c). Overall, we observed a greater proportion of downregulated versus upregulated EV miRNAs in both the 1‐ and 2‐ppm O3‐exposed groups compared to FA (Figure 3b and c). Hierarchical clustering of the 50 most variably expressed EV miRNAs revealed several different concentration‐response patterns of expression including monotonic and non‐monotonic relationships (Figure 4a), as we previously observed for mRNAs (Tovar et al., 2020). An apparent threshold effect was observed for the bulk of EV miRNAs, illustrated by the closer correlation of the FA and 1‐ppm O3 groups compared to the 2‐ppm O3 group (Figure 4a). The most highly upregulated EV miRNA after both 1 and 2 ppm O3 exposure was miR‐2137 (Figure 4b) as well as several miR‐2137 isomiRs generated by alternative processing or nucleotide additions (Supplemental Figure S6). In addition to miR‐2137, miR‐126‐3p was one of the few upregulated miRNAs overall (~3.0‐ and 4.4‐fold in 1 and 2 ppm O3, respectively, vs. FA) (Figure 4b). The most highly downregulated miRNAs were miR‐378‐3p (~6.8‐ and 2.3‐fold, 1 and 2 ppm O3 vs. FA) and miR‐351‐5p (~1.5‐ and 5.3‐fold, 1 and 2 ppm O3, respectively, vs. FA) (Figure 4b).

FIGURE 3.

FIGURE 3

O3 exposure alters airway extracellular vesicle miRNA expression. (A) Principal components analysis showing separation of pooled airway EV samples by exposure group. (B and C) Volcano plots showing differentially expressed (DE) miRNAs in 1 ppm O3 versus FA (16 DE miRNAs) and 2 ppm O3 versus FA (99 DE miRNAs), respectively (horizontal line: p ‐adjusted = 0.05, vertical lines: absolute fold change of ±2). N = 3 EV RNA samples per exposure group, where each sample is a pool of 3–4 individual mice

FIGURE 4.

FIGURE 4

Specific O3‐induced alterations of the EV miRNA landscape. (A) Unsupervised hierarchical clustering analysis of the top 50 most variable EV miRNAs. Data are presented as mean‐centered, log2‐transformed reads per million miRNAs mapped (RPMMM) for each miRNA. (B) Expression of selected O3‐responsive EV miRNAs. Box‐and‐Whisker plots depict RPMMM summarized by the minimum, first quartile, median, third quartile, and maximum with all points overlaid. n = 3 pooled samples per group

3.4. Integration of EV miRNA and tissue mRNA data to identify putative regulatory relationships

Previously, we characterized the transcriptional profiles of airway macrophages and conducting airway tissue of mice exposed to O3 (Tovar et al., 2020). We integrated those mRNA expression data with the EV miRNA data presented here as a strategy to identify EV miRNAs that may cause the observed changes in tissue mRNA expression. Specifically, we sought to identify EV miRNAs that could plausibly regulate sets of target mRNAs in recipient airway macrophage or conducting airway tissue. Given the canonical role of miRNAs in decreasing mRNA levels and/or inhibiting mRNA translation (Bartel, 2018), we focused our analysis on EV miRNAs whose expression was directionally opposed to the tissue mRNA patterns across the exposure groups (i.e., we paired miRNAs that increased after 1 and 2 ppm O3 with mRNAs that correspondingly decreased, or vice versa), and we stipulated that both miRNA and mRNA must be significantly differentially expressed for the designated contrast.

Our analysis of regulatory relationships using miRhub identified several miRNAs that were predicted to target sets of genes in airway macrophages or conducting airways (the full set of results are shown in Supplemental Figure S7). EV miR‐22‐3p emerged as a particularly interesting candidate regulator of gene expression in airway macrophages (Figure 5a) because it was highly expressed (>1,000 RPMMM) and was predicted to target seven downregulated genes (Kdm6b, Stk39, Btg1, N4bp2, Sp1, Dpysl3, and Cnot6l). The pattern of O3‐induced expression of EV miR‐22‐3p is shown alongside expression in airway macrophages of one of its predicted target genes, Btg1 (Figure 5b). Finally, we validated the effect of 2 ppm O3 on EV miR‐22‐3p expression in an independent experiment (Supplemental Figure S8).

FIGURE 5.

FIGURE 5

Identification of candidate EV miRNA regulators of O3‐induced transcriptional responses. (A) Results of miRNA target site enrichment analysis, conducted using miRhub, on genes downregulated by 2 ppm O3 versus FA in airway macrophages. Data points are plotted as –log10(p‐value) versus miRNA family and are highlighted if a member of the miRNA family was found to be differentially expressed in airway EVs. (B) Plot depicting RPMMM for EV miR‐22‐3p alongside expression of a predicted airway macrophage mRNA target, Btg1 (normalized counts from DESeq2), and the miR‐22‐3p target site in Btg1 from TargetScan mouse release 7.2. n = 3 or 4 (mRNA data) pooled samples per group

4. DISCUSSION

In this study, we examined the effects of exposure to the common air pollutant O3 on the murine lung EV landscape and focused in particular on changes in EV small RNA content. We observed an increase in the number of EVs in the lungs in parallel with markers of inflammation (macrophages, neutrophils) and injury (total protein) following O3 exposure. O3 exposure also changed the profile of lung EV small RNAs, with 16 and 99 miRNAs up‐ and downregulated by 1 and 2 ppm O3, respectively. Our data suggest that these biologically active EV cargo are O3‐responsive, and as such, may play a role in regulating O3‐induced inflammation. We note that because we chose to use female mice, based on evidence of greater airway neutrophilia and inflammatory cytokine production in this sex (Cabello et al., 2015; Mishra et al., 2016), the sex‐dependence of our results is not known and thus should be addressed in future studies.

We isolated EVs from BALF, which, prior to processing represents a complex mixture of small molecules, lavageable cells, larger debris, and nanoparticles (40–1000 nm). These nanoparticles include both the lipid membrane‐bound EVs of interest and non‐EV particles such as protein‐aggregates. To process our BALF samples for EV isolation, we performed a centrifugation at 16,000 x g to remove apoptotic bodies and large debris, which resulted in depletion of particles greater than 400 nm. In these samples, we observed an increase in particles due to O3 exposure that was most evident in the size range of ~80–150 nm size range and a decrease in the size mode from ~120 to 100 nm, suggestive of exosome and small microvesicles (Raposo & Stoorvogel, 2013). Although these data only provide a rough estimate of the particle type and it is not possible to rule‐out a contribution of non‐EV particles, we confirmed that the O3‐induced increase in the number of particles was present after EVs were isolated from the BALF using membrane affinity column isolation.

Our characterization of surface marker expression in eluted EVs further demonstrated that the BALF EVs we isolated were composed primarily of exosomes and microvesicles, identified by typical exosome (CD81, CD9, and CD63) and microvesicle markers (CD51 and CD31) (Théry et al., 2019). EVs positive for the exosome marker CD81 predominated and appear to be more responsive to O3. Lung EVs derive from multiple cell types, and the largest proportion of EVs were Siglec‐F positive, suggestive of an alveolar macrophage origin. However, Siglec‐F‐positive EVs (CD81 and Siglec‐F) comprised only ~1.5–4% of the total population of EVs. We also observed a small set of CD11b‐positive EVs, indicative of monocytes/macrophage origin. Somewhat surprisingly, we identified few particles of epithelial cell origin, as evidenced by less than one percent EpCAM‐positive EVs in both the FA and O3 groups. Previous studies, using standard flow cytometry and different markers, identified greater proportions of epithelial cell‐ derived EVs in BALF samples collected from controls and following exposure to other inflammatory stimuli (Lee et al., 2018; Moon et al., 2015). Overall, differences in cell‐type origin were less dynamic in our study; other than a small but statistically significant increase in CD81‐ and Ly6G‐positive particles (indicative of neutrophil derived EVs), O3‐induced effects on surface marker expression were not observed. However, we do note that an important role for neutrophil‐derived EVs has been observed in a mouse model of COPD (Genschmer et al., 2019).

Our global genomic approach allowed us to identify changes in miRNA content of EVs derived from multiple cell types, but the question of which EV‐derived miRNAs come from which cell type remains challenging. In general, there were few O3‐induced changes in EV marker expression, suggesting that changes in cellular sources are not likely to explain the bulk of O3‐induced EV small miRNA expression changes (or other small RNA species). Future studies to delineate the regional and cellular sources of specific EV‐derived small RNA using flow‐sorting and/or fluorescence microscopy and microdissection based approaches would be worthwhile. Nevertheless, by using a global EV collection and small RNA‐seq approach, we identified a host of differentially expressed airway EV miRNAs following O3 exposure and specific miRNAs that may regulate transcriptional responses to O3 in the lung.

The overall number of differentially expressed EV miRNAs and magnitude of change in their expression was concentration‐dependent, with more differentially expressed EV miRNAs in the 2‐ versus 1‐ppm O3 group. Additionally, the majority of differentially expressed miRNA was downregulated, which may reflect either a selective decrease in EV loading or a loss of the miRNA’s cellular source due to toxicity. miR‐2137 was identified as the most highly upregulated and expressed EV miRNA across both the 1 (~14‐fold) and 2 ppm O3 (~120‐fold) groups. Recently, differential expression of miR‐2137 was observed in bone marrow‐derived macrophages after infection with Porphyromonas gingivalis bacteria (Huck et al., 2017), and inhibiting miR‐2137 increased expression of the anti‐inflammatory cytokine IL‐10, suggesting that miR‐2137 may be pro‐inflammatory following O3 exposure. We also observed an O3‐induced upregulation of EV miR‐126‐3p, a well‐studied pro‐inflammatory miRNA (Fogel et al., 2019). miR‐126‐3p is upregulated in inflammatory bowel disease (IBD), in which it targets nuclear factor‐kappaB inhibitor alpha (IκB) (Feng et al., 2012; Wu et al., 2008) and impairs intestinal epithelial barrier function (Chen et al., 2017). We observed a downregulation of miR‐378‐3p, whose overexpression has been shown to negatively regulate macrophage proliferation (Rückerl et al., 2012). Therefore, the known O3‐induced increase in macrophage proliferation is consistent with our results and a potential regulatory effect of EV miR‐378‐3p (Hotchkiss et al., 1989). miR‐351 was also downregulated, and recent evidence suggests that downregulation of miR‐351‐5p is anti‐inflammatory in ischemia/reperfusion injury (Zheng et al., 2019). As such, miR‐351‐5p may represent a pro‐resolving signal after O3 exposure. In general, our data suggest that lung EVs collected 21 h following O3 exposure contain a mixture of both pro‐inflammatory and pro‐resolving signals.

Our integrative bioinformatics analysis of EV miRNA expression identified miR‐22‐3p as a putative regulator of airway macrophage gene expression following O3 exposure. A validated target (Huang et al., 2020) of miR‐22‐3p, Btg1, exhibited a concentration‐response pattern of expression in airway macrophages consistent with miR‐22‐3p regulation. The product of Btg1, B‐cell translocation gene 1 (BTG1), is known to suppress cell growth and proliferation (Yuniati et al., 2019). Interestingly, miR‐22‐3p is differentially expressed across the continuum of polarized human macrophages (Cobos Jiménez et al., 2014) and can promote M2 polarization of macrophages by suppressing interferon regulatory factor 5 (IRF5) (Fang et al., 2021). These data suggest miR‐22‐3p may regulate anti‐inflammatory activities of airway macrophages following O3 exposure (Sunil et al., 2012). Surprisingly, although we identified putative miRNA regulators for genes expressed in conducting airway tissue, none of these miRNAs were differentially expressed in EVs due to O3 exposure. This could be due to timing; for example, an upregulated EV miRNA could have influenced gene expression in conducting airway tissue at a different time point and was no longer or not yet differentially expressed in EVs at 21 h. This may explain why miR‐2137 was not a predicted regulatory hub in either tissue despite its high expression in EVs. Overall, our results suggest that changes in EV miRNAs have a larger effect on gene expression in macrophages versus conducting airways at this time point.

In addition to quantifying specific miRNA expression, our small RNA sequencing approach also revealed the overall proportions of multiple small RNA species present in BALF EVs, including tRNAs, piRNA, and yRNA. We found the majority of BALF EV small RNA reads, from 60 to 90% across exposure groups, mapped to tRNAs. A recent study reported a high percentage of tRNA‐mapped reads in rodent serum EVs (Zhao et al., 2020). The tRNA content of our samples is consistent with tRNA‐derived RNA fragments (tDRs) based on read length. The biology of tDRs is not well understood; however, evidence suggests they may function similarly to miRNAs by regulating gene expression through RNA interference among other suggested functions (Soares & Santos, 2017). Thus, the precise annotation and quantification of O3‐induced murine EV tDRs may reveal additional biological insights into ozone's mechanism of action.

In conclusion, we show that the release of airway EVs and dysregulation of EV miRNA content are features of respiratory tract response to O3 exposure. In addition to O3‐induced increases in the number of EVs and EV miRNA content, O3 also induced broad changes in the quantity of other EV small RNA species such as tRNAs. Our findings contribute to the growing body of evidence that EV miRNAs are both altered by and regulate inflammation in a range of mucosal tissues, including airway responses to O3 and provide compelling support for a range of mechanistic follow‐up studies. In particular, addressing the question of whether changes in EV number and/or content, including miR‐22‐3p and miR‐2137 specifically, are responsible for changes in gene expression in macrophages and other cell types and consequently aspects of O3‐induced airway inflammation or the resolution thereof.

AUTHOR CONTRIBUTIONS

G.J.S. conceived and designed the studies with guidance from S.N.P.K and P.S.; G.J.S. and A.T. performed the experiments; G.J.S and M.K. analyzed the data; J.S.D. and Y.W. conducted the imaging flow cytometry analyses, G.J.S and S.N.P.K. prepared the manuscript; all authors approved the final version of the manuscript.

Supporting information

Fig S1‐S8

Supplementary Material

ACKNOWLEDGMENTS

The authors acknowledge the expert assistance of Kathryn McFadden with mouse experiments, Dr. Rowan Beck for assistance with miRhub analysis, Dr. Mike Love for consultation on analysis of RNA‐seq data, and the UNC High‐Throughput Sequencing Facility (library preparation and small RNA‐seq).

Smith, G. J., Tovar, A., Kanke, M., Wang, Y., Deshane, J. S., Sethupathy, P., & Kelada, S. N. P. (2021). Ozone‐induced changes in the murine lung extracellular vesicle small RNA landscape. Physiological Reports, 9, e15054. 10.14814/phy2.15054

Funding information

This research was supported by NIH Grants ES024965, a UNC Center for Environmental Health and Susceptibility Pilot Project Award (through P30ES010126), a T32 training grant (ES007126‐35), and a Leon and Bertha Golberg Postdoctoral Fellowship from the UNC Curriculum in Toxicology and Environmental Medicine.

Data Availability Statement

All sequencing data have been uploaded to the NCBI Gene Expression Omnibus (GEO) under accession number: GSE181645. All phenotype data are included in the Supplemental Data Tables S1 and S2.

REFERENCES

  1. Al‐Hegelan, M., Tighe, R. M., Castillo, C., & Hollingsworth, J. W. (2011). Ambient ozone and pulmonary innate immunity. Immunologic Research, 49, 173–191. 10.1007/s12026-010-8180-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Andres, J., Smith, L. C., Murray, A., Jin, Y., Businaro, R., Laskin, J. D., & Laskin, D. L. (2020). Role of extracellular vesicles in cell‐cell communication and inflammation following exposure to pulmonary toxicants. Cytokine & Growth Factor Reviews, 51, 12–18. 10.1016/j.cytogfr.2019.12.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baran‐Gale, J., Fannin, E. E., Kurtz, C. L., & Sethupathy, P. (2013). Beta Cell 5’‐shifted isomirs are candidate regulatory hubs in type 2 diabetes. PLoS One, 8, e73240. 10.1371/journal.pone.0073240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bartel, D. P. (2018). Metazoan MicroRNAs. Cell, 173(1), 20–51. 10.1016/j.cell.2018.03.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Behndig, A. F., Blomberg, A., Helleday, R., Duggan, S. T., Kelly, F. J., & Mudway, I. S. (2009). Antioxidant responses to acute ozone challenge in the healthy human airway. Inhalation Toxicology, 21, 933–942. 10.1080/08958370802603789. [DOI] [PubMed] [Google Scholar]
  6. Cabello, N., Mishra, V., Sinha, U., DiAngelo, S. L., Chroneos, Z. C., Ekpa, N. A., Cooper, T. K., Caruso, C. R., & Silveyra, P. (2015). Sex differences in the expression of lung inflammatory mediators in response to ozone. American Journal of Physiology‐Lung Cellular and Molecular Physiology, 309, L1150–L1163. 10.1152/ajplung.00018.2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chen, T., Xue, H., Lin, R., & Huang, Z. (2017). MiR‐126 impairs the intestinal barrier function via inhibiting S1PR2 mediated activation of PI3K/AKT signaling pathway. Biochemical and Biophysical Research Communications, 494, 427–432. 10.1016/j.bbrc.2017.03.043. [DOI] [PubMed] [Google Scholar]
  8. Cho, H.‐Y., Gladwell, W., Yamamoto, M., & Kleeberger, S. R. (2013). Exacerbated Airway Toxicity of environmental oxidant ozone in mice deficient in Nrf2. Oxidative Medicine Cellular Longevity, 2013, 254069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cobos Jiménez, V., Bradley, E. J., Willemsen, A. M., van Kampen, A. H. C., Baas, F., & Kootstra, N. A. (2014). Next‐generation sequencing of microRNAs uncovers expression signatures in polarized macrophages. Physiological Genomics, 46, 91–103. 10.1152/physiolgenomics.00140.2013. [DOI] [PubMed] [Google Scholar]
  10. Crescitelli, R., Lässer, C., Szabó, T. G., Kittel, A., Eldh, M., Dianzani, I., Buzás, E. I., & Lötvall, J. (2013). Distinct RNA profiles in subpopulations of extracellular vesicles: Apoptotic bodies, microvesicles and exosomes. Journal of Extracellularr Vesicles, 2, 20677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Devlin, R. B., McDonnell, W. F., Mann, R., Becker, S., House, D. E., Schreinemachers, D., & Koren, H. S. (1991). Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung. American Journal of Respiratory Cell and Molecular Biology, 4, 72–81. 10.1165/ajrcmb/4.1.72. [DOI] [PubMed] [Google Scholar]
  12. Fakhrzadeh, L., Laskin, J. D., & Laskin, D. L. (2008). Regulation of caveolin‐1 expression, nitric oxide production and tissue injury by tumor necrosis factor‐ α following ozone inhalation. Toxicology and Applied Pharmacology, 227, 380–389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fang, H., Yang, M., Pan, Q., Jin, H.‐L., Li, H.‐F., Wang, R.‐R., Wang, Q.‐Y., & Zhang, J.‐P. (2021). MicroRNA‐22‐3p alleviates spinal cord ischemia/reperfusion injury by modulating M2 macrophage polarization via IRF5. Journal of Neurochemistry, 156, 106–120. 10.1111/jnc.15042. [DOI] [PubMed] [Google Scholar]
  14. Feng, X., Wang, H., Ye, S., Guan, J., Tan, W., Cheng, S., Wei, G., Wu, W., Wu, F., & Zhou, Y. (2012). Up‐Regulation of microRNA‐126 may contribute to pathogenesis of ulcerative colitis via regulating NF‐kappaB inhibitor IκBα. PLoS One, 7, e52782. 10.1371/journal.pone.0052782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fogel, O., Bugge Tinggaard, A., Fagny, M., Sigrist, N., Roche, E., Leclere, L., Deleuze, J. F., Batteux, F., Dougados, M., Miceli‐Richard, C., & Tost, J. (2019). Deregulation of microRNA expression in monocytes and CD4+ T lymphocytes from patients with axial spondyloarthritis. Arthritis Research & Therapy, 21, 1–14. 10.1186/s13075-019-1829-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Fujita, Y., Araya, J., Ito, S., Kobayashi, K., Kosaka, N., Yoshioka, Y., Kadota, T., Hara, H., Kuwano, K., & Ochiya, T. (2015). Suppression of autophagy by extracellular vesicles promotes myofibroblast differentiation in COPD pathogenesis. Journal of Extracellular Vesicles, 4, 28388. 10.3402/jev.v4.28388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Genschmer, K. R., Russell, D. W., Lal, C., Szul, T., Bratcher, P. E., Noerager, B. D., Abdul Roda, M., Xu, X., Rezonzew, G., Viera, L., Dobosh, B. S., Margaroli, C., Abdalla, T. H., King, R. W., McNicholas, C. M., Wells, J. M., Dransfield, M. T., Tirouvanziam, R., Gaggar, A., & Blalock, J. E. (2019). Activated PMN exosomes: pathogenic entities causing matrix destruction and disease in the lung. Cell, 176, 113–126.e15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gilmour, M. I., Hmieleski, R. R., Stafford, E. A., & Jakab, G. J. (1991). Suppression and recovery of the alveolar macrophage phagocytic system during continuous exposure to 0.5 ppm ozone. Experimental Lung Research, 17, 547–558. 10.3109/01902149109062864. [DOI] [PubMed] [Google Scholar]
  19. Guiot, J., Struman, I., Louis, E., Louis, R., Malaise, M., & Njock, M.‐S. (2019). Exosomal miRNAs in lung diseases: From biologic function to therapeutic targets. Journal of Clinical Medicine, 8, 1345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Gupta, R., Radicioni, G., Abdelwahab, S., Dang, H., Carpenter, J., Chua, M., Mieczkowski, P. A., Sheridan, J. T., Randell, S. H., & Kesimer, M. (2019). Intercellular communication between airway epithelial cells is mediated by exosome‐like vesicles. American Journal of Respiratory Cell and Molecular Biology, 60, 209–220. 10.1165/rcmb.2018-0156OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Haque, R., Umstead, T. M., Ponnuru, P., Guo, X., Hawgood, S., Phelps, D. S., & Floros, J. (2007). Role of surfactant protein‐A (SP‐A) in lung injury in response to acute ozone exposure of SP‐A deficient mice. Toxicology and Applied Pharmacology, 220, 72–82. 10.1016/j.taap.2006.12.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hollingsworth, J. W., Kleeberger, S. R., & Foster, W. M. (2007). Ozone and pulmonary innate immunity. Proceedings of the American Thoracic Society, 4, 240–246. 10.1513/pats.200701-023AW. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hotchkiss, J. A., Harkema, J. R., Kirkpatrick, D. T., & Henderson, R. F. (1989). Response of rat alveolar macrophages to ozone: Quantitative assessment of population size, morphology, and proliferation following acute exposure. Experimental Lung Research, 15, 1–16. [DOI] [PubMed] [Google Scholar]
  24. Hough, K. P., Wilson, L. S., Trevor, J. L., Strenkowski, J. G., Maina, N., Il, K. Y., Spell, M. L., Wang, Y., Chanda, D., Dager, J. R., Sharma, N. S., Curtiss, M., Antony, V. B., Dransfield, M. T., Chaplin, D. D., Steele, C., Barnes, S., Duncan, S. R., Prasain, J. K., … Deshane, J. S. (2018). Unique lipid signatures of extracellular vesicles from the airways of asthmatics. Scientific Reports, 8, 1–16. 10.1038/s41598-018-28655-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Huang, H. Y., Lin, Y. C. D., Li, J., Huang, K. Y., Shrestha, S., Hong, H. C., Tang, Y., Chen, Y. G., Jin, C. N., Yu, Y., Xu, J. T., Li, Y. M., Cai, X. X., Zhou, Z. Y., Chen, X. H., Pei, Y. Y., Hu, L., Su, J. J., Cui, S. D., … Da, H. H. (2020). MiRTarBase 2020: Updates to the experimentally validated microRNA‐target interaction database. Nucleic Acids Research, 48, D148–D154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Huck, O., Al‐Hashemi, J., Poidevin, L., Poch, O., Davideau, J. L., Tenenbaum, H., & Amare, S. (2017). Identification and characterization of microRNA differentially expressed in macrophages exposed to Porphyromonas gingivalis infection. Infection and Immunity, 85, e00771‐16. 10.1128/IAI.00771-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Inoue, K., Takano, H., Kaewamatawong, T., Shimada, A., Suzuki, J., Yanagisawa, R., Tasaka, S., Ishizaka, A., & Satoh, M. (2008). Role of metallothionein in lung inflammation induced by ozone exposure in mice. Free Radical Biology and Medicine, 45, 1714–1722. 10.1016/j.freeradbiomed.2008.09.008. [DOI] [PubMed] [Google Scholar]
  28. Ismail, N., Wang, Y., Dakhlallah, D., Moldovan, L., Agarwal, K., Batte, K., Shah, P., Wisler, J., Eubank, T. D., Tridandapani, S., Paulaitis, M. E., Piper, M. G., & Marsh, C. B. (2013). Macrophage microvesicles induce macrophage differentiation and miR‐223 transfer. Blood, 121, 984–995. 10.1182/blood-2011-08-374793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Jaspers, I., Flescher, E., & Chen, L. C. (1997). Ozone‐induced IL‐8 expression and transcription factor binding in respiratory epithelial cells. American Journal of Physiology‐Lung Cellular and Molecular Physiology, 272(3), L504–L511. 10.1152/ajplung.1997.272.3.L504. [DOI] [PubMed] [Google Scholar]
  30. Kanke, M., Baran‐Gale, J., Villanueva, J., & Sethupathy, P. (2016). miRquant 2.0: An expanded tool for accurate annotation and quantification of MicroRNAs and their isomiRs from small RNA‐sequencing data. Journal of Integrative Bioinformatics, 13, 307. [DOI] [PubMed] [Google Scholar]
  31. Kesic, M. J., Meyer, M., Bauer, R., & Jaspers, I. (2012). Exposure to ozone modulates human airway protease/antiprotease balance contributing to increased influenza A infection. PLoS One, 7, 1–12. 10.1371/journal.pone.0035108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kilburg‐Basnyat, B., Reece, S. W., Crouch, M. J., Luo, B., Boone, A. D., Yaeger, M., Hodge, M., Psaltis, C., Hannan, J. L., Manke, J., Armstrong, M. L., Reisdorph, N., Tighe, R. M., Shaikh, S. R., & Gowdy, K. M. Specialized pro‐resolving lipid mediators regulate ozone‐induced pulmonary and systemic inflammation. Toxicological Sciences, 163(2), 466–477. 10.1093/toxsci/kfy040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Kim, C. S., Alexis, N. E., Rappold, A. G., Kehrl, H., Hazucha, M. J., Lay, J. C., Schmitt, M. T., Case, M., Devlin, R. B., Peden, D. B., & Diaz‐Sanchez, D. (2011). Lung function and inflammatory responses in healthy young adults exposed to 0.06 ppm ozone for 6.6 hours. American Journal of Respiratory and Critical Care Medicine, 183, 1215–1221. 10.1164/rccm.201011-1813OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Lay, J. C., Alexis, N. E., Kleeberger, S. R., Roubey, R. A. S., Harris, B. D., Bromberg, P. A., Hazucha, M. J., Devlin, R. B., & Peden, D. B. Ozone enhances markers of innate immunity and antigen presentation on airway monocytes in healthy individuals. Journal of Allergy and Clinical Immunology, 120(3), 719–722. 10.1016/j.jaci.2007.05.005. [DOI] [PubMed] [Google Scholar]
  35. Lee, H., Li, C., Zhang, Y., Zhang, D., Otterbein, L. E., & Jin, Y. (2019). Caveolin‐1 selectively regulates microRNA sorting into microvesicles after noxious stimuli. Journal of Experimental Medicine, 216, 2202–2220. 10.1084/jem.20182313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Lee, H., Zhang, D., Laskin, D. L., & Jin, Y. (2018). Functional evidence of pulmonary extracellular vesicles in infectious and noninfectious lung inflammation. The Journal of Immunology, 201(5), 1500–1509. 10.4049/jimmunol.1800264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Levänen, B., Bhakta, N. R., Torregrosa Paredes, P., Barbeau, R., Hiltbrunner, S., Pollack, J. L., Sköld, C. M., Svartengren, M., Grunewald, J., Gabrielsson, S., Eklund, A., Larsson, B. M., Woodruff, P. G., Erle, D. J., & Wheelock, Å. M. (2013). Altered microRNA profiles in bronchoalveolar lavage fluid exosomes in asthmatic patients. The Journal of Allergy and Clinical Immunology, 131, 18–23. 10.1016/j.jaci.2012.11.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. McVey, M. J., Maishan, M., Blokland, K. E. C., Bartlett, N., & Kuebler, W. M. (2019). Extracellular vesicles in lung health, disease, and therapy. American Journal of Physiology‐Lung Cellular and Molecular Physiology, 316(6), L977–L989. 10.1152/ajplung.00546.2018. [DOI] [PubMed] [Google Scholar]
  39. Michaudel, C., Couturier‐Maillard, A., Chenuet, P., Maillet, I., Mura, C., Couillin, I., Gombault, A., Quesniaux, V. F., Huaux, F., & Ryffel, B. (2016). Inflammasome, IL‐1 and inflammation in ozone‐induced lung injury. American Journal of Clinical Experimental Immunology, 5, 33–40. [PMC free article] [PubMed] [Google Scholar]
  40. Mishra, V., DiAngelo, S. L., & Silveyra, P. (2016). Sex‐specific IL‐6‐associated signaling activation in ozone‐induced lung inflammation. Biology of Sex Differences, 7, 16. 10.1186/s13293-016-0069-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Moon, H., Cao, Y., Yang, J., Lee, J. H., Choi, H. S., & Jin, Y. (2015). Lung epithelial cell‐derived extracellular vesicles activate macrophage‐mediated inflammatory responses via ROCK1 pathway. Cell Death & Disease, 6, e2016. 10.1038/cddis.2015.282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Mudway, I. S., & Kelly, F. J. (2000). Ozone and the lung: A sensitive issue. Molecular Aspects of Medicine, 21, 1–48. [DOI] [PubMed] [Google Scholar]
  43. Nadadur, S. S., Costa, D. L., Slade, R., Silbjoris, R., & Hatch, G. E. (2005). Acute ozone‐induced differential gene expresssion profiles in rat lung. Environmental Health Perspectives, 113, 1717–1722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Njock, M. S., Guiot, J., Henket, M. A., Nivelles, O., Thiry, M., Dequiedt, F., Corhay, J. L., Louis, R. E., & Struman, I. (2018). Sputum exosomes: Promising biomarkers for idiopathic pulmonary fibrosis. Thorax, 74, 309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Pfister, G. G., Walters, S., Lamarque, J.‐F., Fast, J., Barth, M. C., Wong, J., Done, J., Holland, G., & Bruyère, C. L. (2014). Projections of future summertime ozone over the U.S. Journal of Geophysical Research: Atmospheres, 119, 5559–5582. 10.1002/2013JD020932. [DOI] [Google Scholar]
  46. Pryor, W. A., Squadrito, G. L., & Friedman, M. (1995). The cascade mechanism to explain ozone toxicity: The role of lipid ozonation products. Free Radical Biology and Medicine, 19, 935–941. [DOI] [PubMed] [Google Scholar]
  47. Pua, H. H., Happ, H. C., Gray, C. J., Mar, D. J., Chiou, N. T., Hesse, L. E., & Ansel, K. M. (2019). Increased hematopoietic extracellular RNAs and Vesicles in the Lung during Allergic Airway responses. Cell Reports, 26(4), 933.e4–944.e4. 10.1016/j.celrep.2019.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Raposo, G., & Stoorvogel, W. (2013). Extracellular vesicles: Exosomes, microvesicles, and friends. Journal of Cell Biology, 200, 373–383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Rückerl, D., Jenkins, S. J., Laqtom, N. N., Gallagher, I. J., Sutherland, T. E., Duncan, S., Buck, A. H., & Allen, J. E. (2012). Induction of IL‐4Rα‐dependent microRNAs identifies PI3K/Akt signaling as essential for IL‐4‐driven murine macrophage proliferation in vivo. Blood, 120, 2307–2316. 10.1182/blood-2012-02-408252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Saha, B., Momen‐Heravi, F., Kodys, K., & Szabo, G. (2016). MicroRNA cargo of extracellular vesicles from alcohol‐exposed monocytes signals naive monocytes to differentiate into M2 macrophages. Journal of Biological Chemistry, 291, 149–159. 10.1074/jbc.M115.694133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Schönbein, C. F. (1851). On some secondary physiological effects produced by atmospheric electricity. Journal of the Royal Society of Medicine, MCT‐34(1), 205–220. 10.1177/095952875103400117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Smith, G. J., Walsh, L., Higuchi, M., & Kelada, S. N. P. (2019). Development of a large‐scale computer‐controlled ozone inhalation exposure system for rodents. Inhalation Toxicology, 31, 61–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Soares, A. R., & Santos, M. (2017). Discovery and function of transfer RNA‐derived fragments and their role in disease. Wiley Interdiscip Rev RNA, 8, 1–13. 10.1002/wrna.1423. [DOI] [PubMed] [Google Scholar]
  54. Sunil, V. R., Patel‐vayas, K., Shen, J., Laskin, J. D., & Laskin, D. L. (2012). Classical and alternative macrophage activation in the lung following ozone‐induced oxidative stress. Toxicology and Applied Pharmacology, 263, 195–202. 10.1016/j.taap.2012.06.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Théry, C., Witwer, K. W., Aikawa, E., Alcaraz, M. J., Anderson, J. D., Andriantsitohaina, R., Antoniou, A., Arab, T., Archer, F., Atkin‐Smith, G. K., Ayre, D. C., Bach, J.‐M., Bachurski, D., Baharvand, H., Balaj, L., Baldacchino, S., Bauer, N. N., Baxter, A. A., Bebawy, M., … Zuba‐Surma, E. K. (2019). Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. Journal of Extracellular Vesicles, 8, 1535750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Tovar, A., Smith, G. J., Thomas, J. M., Crouse, W. L., Harkema, J. R., & Kelada, S. N. P. (2020). Transcriptional profiling of the murine airway response to acute ozone exposure. Toxicological Sciences, 173(1), 114–130. 10.1093/toxsci/kfz219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. U.S. Environmental Protection Agency . (2020). Nonattainment Areas for Criteria Pollutants [Online]. Green B, https://www.epa.gov/green‐book
  58. Wu, F., Zikusoka, M., Trindade, A., Dassopoulos, T., Harris, M. L., Bayless, T. M., Brant, S. R., Chakravarti, S., & Kwon, J. H. (2008). MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide‐2α. Gastroenterology, 135, 1624.e24–1635.e24. 10.1053/j.gastro.2008.07.068. [DOI] [PubMed] [Google Scholar]
  59. Yoon, H.‐K., Cho, H.‐Y., & Kleeberger, S. R. (2007). Protective role of matrix metalloproteinase‐9 in ozone‐induced airway inflammation. Environmental Health Perspectives, 115, 1557–1563. 10.1289/ehp.10289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Yuniati, L., Scheijen, B., van der Meer, L. T., & van Leeuwen, F. N. (2019). Tumor suppressors BTG1 and BTG2: Beyond growth control. Journal of Cellular Physiology, 234, 5379–5389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Zhang, D., Lee, H., Wang, X., Groot, M., Sharma, L., Dela Cruz, C. S., & Jin, Y. (2019). A potential role of microvesicle‐containing miR‐223/142 in lung inflammation. Thorax, 74, 865–874. 10.1136/thoraxjnl-2018-212994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Zhao, F., Cheng, L., Shao, Q., Chen, Z., Lv, X., Li, J., He, L., Sun, Y., Ji, Q., Lu, P., Ji, Y., & Ji, J. (2020). Characterization of serum small extracellular vesicles and their small RNA contents across humans, rats, and mice. Scientific Reports, 10, 1–16. 10.1038/s41598-020-61098-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Zheng, L., Han, X., Hu, Y., Zhao, X., Yin, L., Xu, L., Qi, Y., Xu, Y., Liu, K., & Peng, J. (2019). Dioscin ameliorates intestinal ischemia/reperfusion injury via adjusting miR‐351‐5p/MAPK13‐mediated inflammation and apoptosis. Pharmacological Research, 139, 431–439. 10.1016/j.phrs.2018.11.040. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Fig S1‐S8

Supplementary Material

Data Availability Statement

All sequencing data have been uploaded to the NCBI Gene Expression Omnibus (GEO) under accession number: GSE181645. All phenotype data are included in the Supplemental Data Tables S1 and S2.


Articles from Physiological Reports are provided here courtesy of Wiley

RESOURCES